1. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study. (November 2020) Authors: Harrison, Stephen A; Ratziu, Vlad; Boursier, Jérôme; Francque, Sven; Bedossa, Pierre; Majd, Zouher; Cordonnier, Geneviève; Sudrik, Fouad Ben; Darteil, Raphael; Liebe, Roman; Magnanensi, Jérémy; Hajji, Yacine; Brozek, John; Roudot, Alice; Staels, Bart; Hum, Dean W; Megnien, Sophie Jeannin; Hosmane... Journal: Lancet gastroenterology and hepatology Issue: Volume 5:Number 11(2020) Page Start: 970 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma–associated adverse cardiac effects. (November 2014) Authors: Hanf, Rémy; Millatt, Lesley J; Cariou, Bertrand; Noel, Benoit; Rigou, Géraldine; Delataille, Philippe; Daix, Valérie; Hum, Dean W; Staels, Bart Journal: Diabetes & vascular disease research Issue: Volume 11:Number 6(2014:Nov.) Page Start: 440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗